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To evaluate the eﬀect of expression of latent membrane protein (LMP) 1 encoded by Epstein-Barr virus (EBV) on Cε mRNA
expression, mRNA levels were examined by RT-PCR or Northern blot analysis upon transient transfection of LMP1 in the spleno-
cytes derived from Brown-Norway rats with or without immunization with 2,4-dinitrophenyl-conjugated Ascaris suum antigen.
Splenocytes were transfected with LMP1 expression vector, pSG5-LMP1, using lipofection method. Cε mRNA levels were consid-
erably increased by transfection with pSG5-LMP1 in the splenocytes derived from the nonimmunized rats; however, Cε mRNA
levels were decreased in the splenocytes derived from the immunized rats. Cε mRNA expression in IgE-producing cells are modu-
lated by LMP1, which might depend on the diﬀerentiation status of B cells upon exposure to allergen.
Copyright © 2006 Kazuhiko Hanashiro et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Epstein-Barr virus (EBV) is a member of the human her-
pesvirus family and latently infects more than 90% of the
world’s adult population. EBV infects the oropharynx tissues
such as tonsils and salivary glands as its primary target tis-
sues. Although EBV is ordinarily dormant in the host for-
everafterprimaryinfection,itsometimesallowsBcellstoac-
quire the unlimited growth potential. Therefore, lymphoma
would be observed in the case of the weak host’s immunore-
sponsiveness tothevirusinfection. EBVis alsoreportedly in-
volved in allergic reactions. Increased levels of EBV antibod-
ies are found both in children with asthma and atopic der-
matitis [1, 2]. In in vitro studies, EBV-transformed B cells
stimulated with IL-4 produce IgE in culture supernatants
[3, 4], and the level of IgE secreted in culture supernatants
correlates with the number of IgE-producing cells[4]. Trans-
formation of B cells by EBV has been reported to increase the
number of IgE-producing cells [5]. Clinical studies to clar-
ify the correlation between EBV infection and serum levels
of IgE, which play a pivotal role in allergic reaction, yielded
however controversial and conﬂicting results [1, 2, 6, 7].
The mechanisms underlying the causal relationship between
the EBV infections and the increase of the risk for allergic
diseases remain to be fully elucidated. There are however
two possible mechanisms underlying there. One of them is
through activating antigen-presenting cells by secretion of
several cytokines including tumor necrosis factor-α (TNFα),
interferon-γ (IFN-γ), and interleukin-1α (IL-1α)f r o mE B V -
activated T cells [8]. Another one is through triggering T-
cell independent class switch DNA recombination (CSR) by
EBV-latentmembraneprotein-1(LMP1)[9].LMP1-induced
CSR in B cells has been reported to be associated with tran-
scriptional activation of germline Cγ,C α,a n dC ε genes and
to trigger the upregulation of activation-induced cytidine
deaminase(AICD),acrucialcomponentoftheCSRmachin-
ery [9]. However, it is yet uncertain how the diﬀerentiation
status of B cells, where EBV-LMP1 is expressed, is associated
with their ability to produce IgE.
The latent gene products encoded by EBV are classiﬁed
into four groups, and at least 9 proteins have been iden-
tiﬁed so far [10]. Of these latent proteins, the LMP1 is a
cell surface protein, which is a receptor-like protein consti-
tutively activated, leading to elicitation of several biological
eﬀects including B-cell transformation. LMP1, a 63-kDa in-
tegral membrane protein consisting of three domains, has
within its C-terminus two activating regions referred to as
C-terminal activating region-1 (CTAR1) and CTAR2 [11].
These CTARs are involved in activation of four diﬀerent
signaling pathways of LMP1, including the nuclear factor2 Mediators of Inﬂammation
κB( N F - κB) pathway [11], which potentially activates im-
munoglobulin gene expression [12]. LMP1 can also protect
the B cell from apoptosis by inducing antiapoptotic proteins
such as BCL-2, MCL-1, and A20 [11]. Therefore, LMP1 can
be regarded as the EBV-encoded protein with the highest po-
tentiality to modulate the immune system involved in IgE
synthesis.
Brown-Norway (BN) rat is a useful experimental ani-
mal for studies on transplantation immunity, heredity, re-
production, aging, and immunoallergy. The BN rat is espe-
cially available for a model of allergic inﬂammation such as
allergic rhinitis, asthma, and food allergy, because it is a high
responder to antigen (allergen) and exhibits high IgE pro-
duction [13, 14].
In the present study, we examined whether or not LMP1
modulates IgE the production of splenocytes derived from
BN rats with or without immunization with 2,4-dinitrop-
henyl-conjugated Ascaris suum antigen (DNP-As) and IgE-
producing hybridoma FE3 cells.
MATERIALS AND METHODS
Animals
BN male rats weighing 200–240g were purchased from
Kyudo Co, Ltd (Kumamoto, Japan). We followed the Stan-
dards Relating to the Care and Management of Experimental
Animals (Notiﬁcation No 6, March 27, 1980, from the Prime
Minister’soﬃce,Tokyo,Japan)forthecareanduseofthean-
imals, together with the University of the Ryukyus guide for
animal experiments. All animal studies were reviewed and
approved by the Animal Care Committee at the University of
the Ryukyus.
Conjugation of dinitrophenyl (DNP) groups to Ascaris
suum(As)extracts
2,4-dinitrobenzene sulfonic acid sodium salt was purchased
from Tokyo Kasei Inc, Ltd (Tokyo, Japan). Protein extraction
from Ascaris suum and conjugation of the extracted proteins
with DNP groups were carried out as described previously
[13].
ImmunizationofBNratswithDNP-As
BN rats were injected with 1mg of DNP-As together with
killed Bordetella pertussis (1010 cells) (Nacalai Tesque, Ky-
oto, Japan), followed by a single booster injection of DNP-As
(0.5mg) 5 days after the ﬁrst injection. Blood samples were
takenfromthetailveinsoftheratsat6,7,8,and10daysafter
the ﬁrst injection.
Enzyme-linked immunosorbent assay for determination
ofserumIgElevels
IgE-capture ELISA was performed as described previously
[13, 15]. In brief, the ELISA plate was coated with 5μg/mL
of rabbit antibodies against IgE FE-3 overnight at 4◦C. After
blocking with 1% gelatin-PBS, the wells were incubated with
the rat serum appropriately diluted with 1% gelatin-PBS
containing 0.05% Tween 20 (PBST) for 1 hour at room
temperature. Following washing, the wells were incubated
with 1μg/mL of biotinylated DNP-As in 1% gelatin-PBST
for 30 minutes at room temperature. After further washing,
the wells were incubated with POD-conjugated streptavidin
(ZYMED Laboratories, Calif, USA) in 1% gelatin-PBST for
30 minutes at room temperature, followed by ﬁnal washing
and addition of substrate solution (ABTS) (Sigma-Aldrich,
Mo, USA). Spectrophotometric readings were then made us-
ingλ1 = 415nmandλ2 = 492nmwavelengthﬁltersofadual
wavelength microplate reader MTP-300 (CORONA Electric,
Ibaraki, Japan).
Preparationofsplenocytes
Nonimmunized and immunized BN rats were anesthetized
with sodium pentobarbiturate, and the spleen was excised
immediately after the rats had been killed by means of bleed-
ing from the carotid artery. The immunized rats were em-
ployed for the experiments 7 days after the ﬁrst immuniza-
tion. The excised spleen was further torn to pieces, and then
splenocytes were collected by centrifugation after removing
these pieces.
Plasmidandtransfection
pSG5-LMP1 was a gift of Dr Kieﬀ (Harvard Medical School,
Mass, USA). The vector was transfected into FE-3 cells or
splenocytes derived from BN rats using DMRIE-C reagent
(Invitrogen, Calif, USA) as follows. 0.5mL of RPMI 1640
medium (Nissui Pharmaceutical Co, Tokyo, Japan) with-
out serum (SFM) was added to each well of a 6-well plate.
Then, 0.8μL of DMRIE-C reagent was added to each well,
and mixed gently by swirling the plate. Furthermore, 0.5mL
SFM containing 0.4μg DNA was added to each well and then
mixed by swirling plate. The plate was incubated at room
temperature for 30 minutes to allow formation of the lipid-
DNA complexes. 2 ×106 cells of FE-3 cells or 2 ×107 cells of
rat splenocytes were placed in the each well in which 0.2mL
SFM had been prepared, and then incubated for 5 hours at
37◦Ci naC O 2 incubator. Two mL growth mediums contain-
ing 15% FBS were then added to each well. In the case of
splenocytes from nonimmunized rats, the cells were cultured
in the presence or absence of 75ng/mL rat IL-4 (Strathmann
Biotec, Germany), because IL-4 is required for the process
of IgE production by B cells [6, 8]. The cells were collected
24 hours after starting plasmid transfection. Irrespective of
cell lineage, no signiﬁcant diﬀerence in the cell viability was
observedbetweencellstransfectedwithpSG5andcellstrans-
fected with pSG5-LMP1.
RNAisolationandNorthernblotanalysis
Total RNA (10μg), prepared using PURESCRIPT RNA Iso-
lation Kit (Gentra System, Minn, USA), was resolved by elec-
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nylon membrane. Ribosomal RNA was stained on the mem-
brane with methylene blue to assess RNA loading and trans-
fer eﬃciency. The procedure of hybridization was followed
by instruction manual directed by Clontech. The Cε and β-
actincDNAsforprobewerepreparedbyRT-PCR.TheLMP1
cDNA for probe was obtained as a restriction fragment of
the pSG5-LMP1. The probes for Northern blot analysis were
then labeled with (α−32P)dCTP using random oligo-primed
reaction.
ReversetranscriptionofmRNA
Reverse transcriptions (RTs) were carried out according to
thestandardprocedures.Inbrief,1μgoftotalRNAin18.8μL
of reaction mixture (4μLo f5 xR Tb u ﬀer, 4μLo f2 . 5m M
dNTP mixture, 2μLo f2 5m MM g C l 2,2μLo f0 . 1MD T T ,
and RNase free water as the rest of mixture) and 0.2μLo f
50μM synthetic oligo(dT) primer were mixed. After dena-
turing at 75◦C for 3 minutes, the reaction was cooled down
on ice and initiated by adding 1μL of M-MLV RTase and in-
cubated for 1 hour at 42◦C.
Polymerasechainreaction(PCR)
The cDNAs for Cε,L M P 1 ,a n dβ-actin genes were ampli-
ﬁed by the PCR method with Program Temp Control System
PC-800 (Astec Inc, Fukuoka, Japan). The reaction was per-
formed in a ﬁnal volume of 20μL of reaction mixture, which
consisted of 20mM Tris-HCl pH 8.4, 50mM KCl, 1.5mM
MgCl2, 0.2mM dNTPs, 0.5μMo fe a c hp r i m e r ,1μLo fT a q
DNA polymerase (Promega, WI, USA) (ﬁnal concentra-
tions), and 1μL of sample. Primer sequences are as follows:
Cε [16], forward, 5 CTTACCTGTCTGGTTTTGGACCTGG
3 ,a n dr e v e r s e ,5  CGGAGGGAAGTGTTACCAGGC 3 ;
β-actin [16], forward, 5 GAGCTATGAGCTGCCTGACGG
3 ,a n dr e v e r s e ,5  TTGCGGTGCACGATGGA 3 ;a n dL M P 1
[17], forward, 5 -TTTGTCTACTCCTACTGATGATCACC-
3 ,andr ev e r se,5  -AGTAGATCCAGAGACCTAAGACAAGT-
3 . The PCR conditions were as follows: a single 5-minute
at 94◦C; 35 cycles (30 cycles for LMP1; 25 cycles for β-
actin) of 94◦Cf o r1m i n u t e ,5 8 ◦Cf o r1m i n u t e ,a n d7 2 ◦C
for 1 minute; and a single 5-minute extension at 72◦C. PCR
products were run on a 2%-agarose gel, visualized with
ethidium bromide and analyzed using the Gel Doc 1000UV
ﬂuorescent gel documentation system (Bio-Rad Lab, Calif,
USA) with the accompanying Multi-Analyst software (ver-
sion 1.0).
Statisticalanalysis
Statistical analysis was performed by unpaired Student t test
for between-group comparisons. Data are expressed as the
means ± standard deviations (SD). When P<. 05 was ob-
tained, the means were considered to be signiﬁcantly diﬀer-
ent.
RESULTS
PreparationofsplenocytesfromBNratsfollowing
immunizationwithDNP-As
Before collecting splenocytes from the immunized rats, we
ﬁrstly determined to when the splenocytes have to be col-
lected following immunization, based on the changes of IgE
levels determined by ELISA. IgE levels in the immunized rats
begantoriseatda y6,andr eachedapeakatda y8assho wnin
Figure 1. The immunocompetent cells with diversity in their
maturity would exist on the initial stage after booster injec-
tion. This stage is also predicted to be essential for B cells to
be destined to become the IgE-producing plasmacytes. The
splenocytes were therefore collected at the early stage, day 7,
where IgE production was observed to start increasing in the
rat.
EffectofLMP1expressiononCεmRNAlevelsof
splenocytesderivedfromBNratswithout
immunizationwithDNP-As
The splenocytes derived from nonimmunized rats were
transfected with the expression vector pSG5-LMP1, and
then cultured in the presence or absence of rat IL-4. Be-
cause Cε mRNA in the splenocytes derived from nonim-
munized BN rats was not detected on Northern blot anal-
ysis, the eﬀect of LMP1 expression on the Cε mRNA lev-
els in the cells was examined by RT-PCR analysis. Since the
primers for RT-PCR ampliﬁcation of Cε mRNA can am-
plify both germline and mature Cε transcripts, the PCR
bands represent the total amount of germline and ma-
ture Cε transcripts. The splenocytes even without treatment
with IL-4 showed as high levels of Cε mRNA as the cells
treated with IL-4, suggesting that the function of B cells
was regulated by IL-4 derived from T-cell population in the
splenocytes collected. Cε mRNA levels were higher in the
cells transfected with pSG5-LMP1 than those in the con-
trol cells transfected with the empty vector pSG5 (P<. 05,
Figure 2).
EffectofLMP1expressiononCεmRNAlevelsof
splenocytesderivedfromBNratsimmunized
withDNP-As
We next determined Cε mRNA levels in the splenocytes col-
lected form the BN rats immunized with DNP-As on North-
ern blot analysis. Theoretically, (α−32P)-labeled probe for
Cε transcripts can hybridize with both germline and mature
Cε transcripts. The Cε mRNA band could be detected as a
single band, which presumably represents mature Cε tran-
scriptbasedonitssizeoflength.TheresultsindicatedthatCε
mRNA levels were lower in the cells transfected with pSG5-
LMP1 than those in the control cells transfected with pSG5
(Figure 3).4 Mediators of Inﬂammation
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Figure 1: Changes of IgE levels in BN rats following immuniza-
tion with DNP-As. The BN rats were injected with 1mg of DNP-As
together with killed Bordetella pertussis (1010 cells), followed by a
single booster injection of DNP-As (0.5mg) 5 days after the ﬁrst
injection. Blood samples were taken from the tail veins of the rats
at 6, 7, 8, and 10 days after the ﬁrst injection. Serum IgE levels in
the rats were determined by IgE-capture ELISA as described in the
“materials and methods.” The results were expressed as means±SD
of triplicate experiments.
EffectofLMP1expressionCεmRNAlevelsof
IgE-producinghybridoma,FE-3cells
FE-3 cells are an IgE-producing hybridoma established by
hybridizing mouse myeloma cells (SP2/0-Ag14/SF) with rat
splenocytes that were isolated from BN rats immunized with
DNP-As [13]. The cDNA sequence of the Cε3a n dC ε4d o -
mains of IgE FE-3 is identical to that of rat IgE IR162 [15],
indicating that IgE obtained from the hybridoma cells is en-
codedinratimmunoglobulin locus.OurSouthernblotanal-
ysis for the genomic DNA of the FE-3 cells indicates that
switch recombination in the Cε gene locus is accomplished
in the cells (our unpublished data). FE-3 cells are therefore
expected to be available for various allergic experiments as
a model of plasmacytes that constitutively produce IgE an-
tibodies. As shown in Figure 4(a), two bands are seen in
Northern blot. The faster migrating band corresponds to the
mRNA for the secreted form of IgE, whereas the slower band
for the membrane-bound form of IgE. Following the trans-
fection of FE-3 cells with pSG5-LMP1 or pSG5 empty vec-
tor, there is no signiﬁcant diﬀerence in IgE levels between
the cells transfected with pSG5-LMP1 and the control cells
transfected with pSG5 (Figure 4).
DISCUSSION
In the present study, we found that the eﬀect of LMP1 over-
expression on the Cε gene expression in the splenocytes was
diﬀerent depending on the immunization condition of BN
rats. Although IL-4 failed to augment Cε mRNA expression,
overexpression of LMP1 upregulated Cε mRNA expression
in splenocytes derived from nonimmunized rats (Figure 2).
This indicates that LMP1 upregulates Cε mRNA expres-
sionindependentlyofstimulationbyIL-4.Overexpressionof
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Figure 2: Eﬀect of LMP1 expression on Cε mRNA levels of spleno-
cytes derived from nonimmunized BN rats. The pSG5-LMP1 or
empty vector pSG5 was transfected into the splenocytes derived
from nonimmunized BN rats using lipofection method. (a) LMP1
and Cε mRNA expressions including both germline and mature Cε
transcriptsweredeterminedbyRT-PCRasdescribedinthe“materi-
als and methods.” The results of three independent experiments are
shown. (b) Cε mRNA levels are represented by the values normal-
izedtotheintensityofPCRproductsforβ-actin.Dataareexpressed
as means±SD of six independent experiments. ∗P<. 05 for with or
without IL-4 treatment, pSG5-LMP1 versus pSG5.
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Figure 3: Eﬀect of LMP1 expression on Cε mRNA levels of spleno-
cytes derived from BN rats immunized with DNP-As. The pSG5-
LMP1 or empty vector was transfected into the splenocytes derived
from BN rats immunized with DNP-As using lipofecton method.
LMP1 and Cε mRNA expression were determined by Northern blot
analysis as described in the “materials and methods.” The results of
three independent experiments are shown.Kazuhiko Hanashiro et al 5
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Figure 4: Eﬀect of LMP1 expression on Cε mRNA levels of IgE-
producing hybridoma FE-3 cells. The pSG5-LMP1 or empty vec-
tor was transfected into IgE-producing hybridoma FE-3 cells using
lipofection method. (a) LMP1 and Cε mRNA expressions were de-
termined by Northern blot analysis as described in the “materials
and methods.” The results of three independent experiments are
shown. (b) Cε mRNA levels are represented by the values normal-
izedtotheintensityofPCRproductsforβ-actin.Dataareexpressed
as means ±SD of six independent experiments.
L M P 1 ,h o w e v e r ,a b r o g a t e dC ε mRNA expression in spleno-
cytes derived from immunized rats (Figure 3). The underly-
ing mechanism for negative eﬀects of LMP1 on the B cells
diﬀerentiating toward IgE-producing cells is yet unidenti-
ﬁed. The positive eﬀects of LMP1 expression on the B cells
that have no deﬁnitive direction of diﬀerentiation, however,
might be due to the promotion of germline Cε transcrip-
tionandCε generearrangementbyLMP1expression.InIgE-
producing hybridoma FE-3 cells, which had accomplished
gene rearrangement in Cε locus, Cε mRNA levels were not
altered by overexpression of LMP1 (Figure 4).
IncreasedlevelsofEBVantibodiesarefoundbothinchil-
dren with asthma and atopic dermatitis [1, 2], suggesting
EBV infection might promote allergic disease. The correla-
tion between EBV infection and serum IgE level is, however,
controversial and still need to be clariﬁed. Rystedt et al in-
dicated that there was no correlation between EBV antibody
titers and serum IgE levels [2]. Calvani et al reported that the
prevalence of high IgE levels was more frequent in the EBV
negative than in the positive subjects [7]. They also indicated
that this higher prevalence in the EBV negative subjects was
found only in the groups of ﬁve years old or less, whereas
in the 6–19 years group the situation was reversed [7]. On
the contrary, heterophil-positive infectious mononucleosis is
found to be associated with high serum IgE level [6]. In ad-
dition, the increase in IgE level was observed very early in the
course of the disease, mainly within the ﬁrst week, rapidly
followed by a signiﬁcant drop below the preillness levels [6].
Based on these studies, it is anticipated that the host’s im-
munoresponsiveness to virus infection, which varies in pa-
tient age and the passage of time from the primary infec-
tion, seems to inﬂuence the correlation between EBV infec-
tion and the serum IgE level.
The B-cell activating signal for IgE synthesis is derived
through CD40 ligand and IL-4 or IL-13. Both IL-4 and IL-13
are capable of inducing germline Cε transcription in B cells,
because IL-4 and IL-13 receptors share the IL-4Rα chain,
which plays a pivotal role in the induction of germline Cε
transcription, as the common component of both receptors
[18, 19]. Target sites for several transcription factors have
been identiﬁed in the Iε promoter, including STAT6, NF-
κB, PU.1, BSAP, C/EBP (for human) [20–22], and AP-1 (for
mouse) [23, 24]. IL-4 and IL-13 are known to induce activa-
tion of STAT6 [20, 22], which promotes RNA transcription
at the Cε locus and is therefore regarded as the critical regu-
lator for germline Cε transcription. CD40, which belongs to
theTNFreceptorfamily,isamembraneproteinfoundonthe
surface of B cells and serves as the receptor for CD40 ligand
expressing on the cell surface of T cells. CD40 mediates the
activation of several transcription factors including NF-κB
and STAT molecules [25], thereby leading to B-cell prolifera-
tion, antibody class switching, and modulation of apoptosis.
Activation of CD40 signaling pathway in the presence of IL-
4 or IL-13 leads to the expression of AICD [26]. This novel
RNA-editing enzyme plays a key role upstream of the pu-
tative switch recombinase, leading to IgE isotype switching,
matureCεtranscription,andIgEsynthesis[12,27].Thus,IL-
4Rα, which is involved in the activation of overlapping sig-
naling pathways between IL-4 and IL-13, and CD40 signal-
ing pathways are integrated to induce IgE isotype switching,
followedbyIgEsynthesis.εgermlinegenetranscription,class
switchrecombination,andsplicingofε-chaingenetranscript
in the course of IgE synthesis are considered as phenomena
synchronized with the diﬀerentiation process of B cell.
A strong correlation is noted between the IgE response
and the number of circulating atypical lymphocytes in the
heterophil-positive infectious mononucleosis [6]. In vitro
experiments indicate that EBV is an enhancer of IgE produc-
tion. EBV-transformed B cells stimulated with IL-4 are al-
lowed to produce IgE in culture supernatants [3, 4], and the
level of IgE secreted in culture supernatants correlates with
the number of IgE-producing cells [4]. LMP1 is most likely
the EBV-encoded protein with highest activity to modulate
IgE production, because LMP1 is known to mimic CD40
through activating the overlapping signaling pathways be-
tween them. He et al reported that LMP1 triggered T-cell in-
dependent CSR [9]. LMP1-induced CSR is associated with
transcriptional activation of germline Cγ,C α,a n dC ε genes
and triggers the upregulation of AICD [9].6 Mediators of Inﬂammation
The key molecules for the signaling by both LMP1
and CD40 are considered to be the intracellular TNF
receptor-associated factor (TRAF) adapter proteins, which
are recruited to the cytoplasmic C-terminus domains of both
LMP1 and CD40 [28, 29]. LMP1 accomplishes its function
by signaling through four diﬀerent pathways: the NF-κB
pathway, the c-Jun N-terminal kinase ((JNK)-AP-1) path-
way,thep38/mitogenactivatedproteinkinase(MAPK)path-
way, and the Janus kinase ((JAK)-signal transducers and ac-
tivators of transcription (STAT)) pathway [11]. Taken to-
gether, LMP1 is predicted to be involved in Cε gene expres-
sionbyactivatingtheNF-κBpathwayand/orJAK-STATpath-
way.
In conclusion, our ﬁndings suggest that Cε mRNA ex-
pression in IgE-producing cells are modulated by LMP1 gene
expressionandthatthismodulationleadingtochangesinex-
pression levels of Cε mRNA might be dependent on the dif-
ferentiation status of B cells upon exposure to allergen.
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